UNSPSC 51351605: Estradiol or oestradiol

This classification denotes an estrogen with the molecular formula C18H24O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4TI98Z838E, chemically known as estra-1,3,5(10)-triene-3,17-diol (17.beta.)- but generally known as estradiol, which bears US NIH Compound Identifier 450. European Medicines Agency schedules Estradiol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07242MIG. The term ESTRADIOL is an International Non-Proprietary Name.

UNSPSC 51351605 Estradiol or oestradiol is a Commodity code for a specific pharmaceutical hormone used in state and local health care procurement, including hormone replacement therapy, contraceptive formulations, and clinical treatment protocols. State and local governments purchase estradiol through health departments, public hospitals, correctional health systems, school district health clinics, and county medical facilities, typically as part of broader pharmaceutical supply contracts or stand-alone specialty drug purchases. The drug appears in procurement as tablets, patches, injections, or gels depending on clinical application and formulary requirements.

The source material contains no recent state and local contract opportunities tagged to this code. Without posted RFPs, RFQs, IFBs, or ITBs naming estradiol procurement, no geographic concentration, repeat-buyer pattern, or representative solicitation detail can be drawn. Firms pursuing pharmaceutical supply contracts at the state or local level should monitor health department RFQs, cooperative purchasing vehicle catalogs (such as state pharmacy group purchasing organizations), and hospital system ITBs for specialty drug line items, but this specific Commodity code does not reflect active recent sourcing activity in the available opportunity record.